Insider Trading Activity For Capstone Therapeutics Corp. (OTCMKTS:CAPS)
Value Fund L P Biotechnology , Insider of Capstone Therapeutics Corp. (OTCMKTS:CAPS) reportedly Sold 4,341,586 shares of the company’s stock at an average price of 0.06 for a total transaction amount of $260,495.16 SEC Form
Insider Trading History For Capstone Therapeutics Corp. (OTCMKTS:CAPS)
Analyst Ratings For Capstone Therapeutics Corp. (OTCMKTS:CAPS)
These are No ratings tracked in the last 12 months. .
The current consensus rating for Capstone Therapeutics Corp. (OTCMKTS:CAPS) is N/A (Score: NaN) with a consensus target price of N/A
Recent Trading Activity for Capstone Therapeutics Corp. (OTCMKTS:CAPS)
Shares of Capstone Therapeutics Corp. closed the previous trading session at 0.0650 down -0.0050 -7.14% with 400 shares trading hands.